Exagen (XGN) PT Lowered to $19 at Cantor Fitzgerald on Weaker Guidance, but Analyst Maintained Overweight Rating and Positive Outlook, "Would Encourage Investors to Acquire Shares" at Current Valuatio
Go back to Exagen (XGN) PT Lowered to $19 at Cantor Fitzgerald on Weaker Guidance, but Analyst Maintained Overweight Rating and Positive Outlook, "Would Encourage Investors to Acquire Shares" at Current Valuatio| (NASDAQ: XGN) | Delayed: 6.59 -0.18 (2.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.77 | 52 Week High | $0.46 | |||
| Open | $6.81 | 52 Week Low | $0.46 | |||
| Day High | $6.81 | P/E | N/A | |||
| Day Low | $6.56 | EPS | $0.00 | |||
| Volume | 226,822 | |||||
